908 Devices (MASS) Net Cash Flow Growth (1y) (2021 - 2026)
908 Devices (MASS) Net Cash Flow Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -562.77% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 2,827.78% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -395.56% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 168.38% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -103.49% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -114.85% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -215.59% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -54.17% |
| 10 | 908 Devices | 387.65 Mn | 286.12 Mn | 8.34 Mn | 81.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 81.76% |
| Mar 31, 2026 | -108.41% |
| Dec 31, 2025 | 926.02% |
| Sep 30, 2025 | 155.24% |
| Jun 30, 2025 | 69.80% |
| Mar 31, 2025 | 313.64% |
| Dec 31, 2024 | -133.35% |
| Sep 30, 2024 | 87.85% |
| Jun 30, 2024 | -104.77% |
| Mar 31, 2024 | 39.62% |
| Dec 31, 2023 | 152.68% |
| Sep 30, 2023 | 23.40% |
| Jun 30, 2023 | -181.77% |
| Mar 31, 2023 | -2,755.51% |
| Dec 31, 2022 | -106.24% |
| Sep 30, 2022 | -671.23% |
| Jun 30, 2022 | -31.00% |
| Mar 31, 2022 | 90.66% |
| Dec 31, 2021 | -38.89% |
| Sep 30, 2021 | -129.83% |